98 related articles for article (PubMed ID: 2764035)
1. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency.
Wenger DA; DeGala G; Williams C; Taylor HA; Stevenson RE; Pruitt JR; Miller J; Garen PD; Balentine JD
Am J Med Genet; 1989 Jun; 33(2):255-65. PubMed ID: 2764035
[TBL] [Abstract][Full Text] [Related]
2. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
3. [Differential diagnosis of congenital lipidoses by lipid analyses of body fluids, biopsy and autopsy tissue].
Pilz H; Heipertz R
Fortschr Neurol Psychiatr Grenzgeb; 1975 Nov; 43(11):602-17. PubMed ID: 53174
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
Fujibayashi S; Wenger DA
Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
[TBL] [Abstract][Full Text] [Related]
5. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
Rafi MA; Amini S; Zhang XL; Wenger DA
Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
[TBL] [Abstract][Full Text] [Related]
6. Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry.
Whitfield PD; Sharp PC; Johnson DW; Nelson P; Meikle PJ
Mol Genet Metab; 2001 May; 73(1):30-7. PubMed ID: 11350180
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts.
Paton BC; Hughes JL; Harzer K; Poulos A
Eur J Cell Biol; 1990 Feb; 51(1):157-64. PubMed ID: 2109697
[TBL] [Abstract][Full Text] [Related]
9. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.
Schlote W; Harzer K; Christomanou H; Paton BC; Kustermann-Kuhn B; Schmid B; Seeger J; Beudt U; Schuster I; Langenbeck U
Eur J Pediatr; 1991 Jun; 150(8):584-91. PubMed ID: 1683286
[TBL] [Abstract][Full Text] [Related]
12. Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe disease.
Wenger DA
APMIS Suppl; 1993; 40():81-7. PubMed ID: 8311994
[TBL] [Abstract][Full Text] [Related]
13. Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.
Inui K; Emmett M; Wenger DA
Proc Natl Acad Sci U S A; 1983 May; 80(10):3074-7. PubMed ID: 6134282
[TBL] [Abstract][Full Text] [Related]
14. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid activator proteins (SAPs) are stored together with glycosphingolipids in the infantile neuronal ceroid-lipofuscinosis (INCL).
Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
Am J Med Genet; 1995 Jun; 57(2):294-7. PubMed ID: 7668348
[TBL] [Abstract][Full Text] [Related]
16. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
Inui K; Wenger DA
Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
18. [Deficiency of arylsulfatase A activity as a basis of metachromatic leucodystrophy].
Lugowska A; Tylki-Szymańska A
Postepy Biochem; 1996; 42(3):284-9. PubMed ID: 9036380
[No Abstract] [Full Text] [Related]
19. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.
Fujita N; Suzuki K; Vanier MT; Popko B; Maeda N; Klein A; Henseler M; Sandhoff K; Nakayasu H; Suzuki K
Hum Mol Genet; 1996 Jun; 5(6):711-25. PubMed ID: 8776585
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
